Sort by:
Results Per Page:
Orally active, selective EGFR inhibitor
EGFR-kinase inhibitor. Also JAK2, JAK3 inhibitor
Highly potent EGFR-kinase inhibitor
Potent and selective dual ErbB2 (HER-2) and EGFR inhibitor
EGFR/PDGFR-kinase inhibitor
Potent EGFR-kinase inhibitor
Potent EGFR-kinase inhibitor
EGFR kinase inhibitor. Also estrogen and PPARγ ligand
Selective ErbB2 inhibitor
Potent dual EGFR/ErbB2 inhibitor; orally active
Selective inhibitor of EGFR-kinase
Potent ErbB receptor family inhibitor
Negative control for PP 2 (Cat. No. 1407)
Potent ErbB receptor family inhibitor
EGFR inhibitor. Also inhibits Aβ42 fibril formation
Dual irreversible inhibitor of ErbB2 and EGFR
Potent and selective ErbB2 inhibitor
Potent EGFR-kinase inhibitor
Potent, selective EGFR and ErbB2 inhibitor
Potent EGFR and VEGFR inhibitor
High affinity and potent covalent EGFR kinase inhibitor
Highly selective EGFR-kinase inhibitor
JAK3 kinase inhibitor. Also inhibits EGFR
Potent inhibitor of EGFR, ErbB2 and Abl receptor tyrosine kinases
Potent EGFR kinase inhibitor
Potent and selective ErbB2 inhibitor
Potent irreversible pan ErbB inhibitor
Potent and irreversible EGFR inhibitor; orally bioavailable
Potent dual specificity EGFR/HER2 inhibitor; active in vivo
Highly potent EGFR and ErbB2 inhibitor; inhibts wild type and mutated receptors